LASIK and surface ablation in patients treated with amiodarone

• Published in: Archivos de la Sociedad Española de Oftalmología Vol. 91; no. 11; pp. 520 - 525
• Main Authors: Ortega-Usobiaga, J, Llovet-Osuna, F, Reza Djodeyre, M, Cobo-Soriano, R, Llovet-Rausell, A, Baviera-Sabater, J
• Format: Journal Article
• Language: English; Spanish
• Published: Spain 01-11-2016
• Subjects: Adult; Aged; Aged, 80 and over; Amiodarone - adverse effects; Anti-Arrhythmia Agents - adverse effects; Contraindications; Female; Humans; Intraoperative Complications - epidemiology; Intraoperative Complications - etiology; Keratomileusis, Laser In Situ; Male; Middle Aged; Postoperative Complications - epidemiology; Postoperative Complications - etiology; Retrospective Studies; Treatment Outcome; Laser In Situ Keratomileusis; Ablación de superficie; Queratomileusis In Situ Asistida por Láser; Photorefractive Keratectomy; Amiodarona; Queratectomía subepitelial asistida por láser; Amiodarone; Surface ablation; Laser Assisted Sub-Epithelial Keratectomy; Queratectomía Foto-Refractiva
• ISSN: 1989-7286
• DOI: 10.1016/j.oftal.2016.05.005

To determine the anatomical and functional outcomes of corneal refractive surgery in patients on amiodarone, a drug listed as being contraindicated in patients undergoing this procedure.
A retrospective observational study was conducted on all consecutive patients who took amiodarone and who underwent LASIK or surface ablation from January 2003 to December 2014. Functional (visual and refractive) outcomes are described.
A total of 20 patients (33 eyes) were included. No significant intraoperative or postoperative complications were found.
In our experience, LASIK and surface ablation did not produce significant clinical complications in selected patients taking amiodarone. The absolute exclusion of certain systemic medications should be reconsidered.